Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Phenytoin sodium 250mg/5ml solution for injection ampoules
0408020T0AAAAAA
|
Phenytoin sodium (parent) | Phenytoin sodium | Central Nervous System | 2 |
|
Phoniq laryngectomy tube 30mm length (non-fenestrated) size 10
20050600063
|
Phoniq laryngectomy tube 30mm length (non-fenestrated) size 10 | Tracheostomy & Laryngectomy Appliances | Dressings | 2 |
|
Phoniq stoma button long length 14.2mm size 14
20050600052
|
Phoniq stoma button long length 14.2mm size 14 | Tracheostomy & Laryngectomy Appliances | Dressings | 2 |
|
Phoniq stoma button short length 4.8mm size 10
20050600045
|
Phoniq stoma button short length 4.8mm size 10 | Tracheostomy & Laryngectomy Appliances | Dressings | 2 |
|
Phoniq stoma button short length 4.8mm size 14
20050600047
|
Phoniq stoma button short length 4.8mm size 14 | Tracheostomy & Laryngectomy Appliances | Dressings | 2 |
|
Pico 14 dressing kit 10cm x 40cm
20033000050
|
Pico 14 dressing kit 10cm x 40cm | Wound Management & Other Dressings | Dressings | 2 |
|
Pico 14 dressing kit 25cm x 25cm
20033000055
|
Pico 14 dressing kit 25cm x 25cm | Wound Management & Other Dressings | Dressings | 2 |
|
Pico dressing 15cm x 30cm
20030000014
|
Pico dressing 15cm x 30cm | Wound Management & Other Dressings | Dressings | 2 |
|
Pimozide 2mg/5ml oral suspension
0402010R0AAAHAH
|
Pimozide | Pimozide | Central Nervous System | 2 |
|
Pirfenidone 267mg tablets
0311010B0AAABAB
|
Pirfenidone | Pirfenidone | Respiratory System | 2 |
|
Piriton Allergy 4mg tablets
0304010G0BCAHAC
|
Piriton | Chlorphenamine maleate | Respiratory System | 2 |
|
Plaquenil 200mg tablets
1001030C0BBAAAA
|
Plaquenil | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | 2 |
|
Pollenase Hayfever Relief for Adults 50microg/dose nsl spy
1202010C0BKACAA
|
Pollenase (Nasal) | Beclometasone dipropionate | Ear, Nose and Oropharynx | 2 |
|
Polyvinyl alcohol 1.4% eye drops preservative free
1108010Q0AAAIAI
|
Polyvinyl alcohol | Polyvinyl alcohol | Eye | 2 |
|
Portex tracheostomy tube holder with velcro fastening adult
20050500012
|
Portex tracheostomy tube holder with velcro fastening adult | Tracheostomy & Laryngectomy Appliances | Dressings | 2 |
|
Potassium bicarbonate 500mg/5ml oral liquid
0902013P0AAAJAJ
|
Potassium bicarbonate | Potassium bicarbonate | Nutrition and Blood | 2 |
|
Potassium chloride 1g/5ml oral solution
0902011U0AAAYAY
|
Potassium chloride (Systemic) | Potassium chloride | Nutrition and Blood | 2 |
|
Potassium chloride 600mg (potassium 8mmol) MR caps
0902011U0AABJBJ
|
Potassium chloride (Systemic) | Potassium chloride | Nutrition and Blood | 2 |
|
Prazosin 500micrograms/5ml oral liquid
0205040S0AAAIAI
|
Prazosin hydrochloride | Prazosin hydrochloride | Cardiovascular System | 2 |
|
Prednisolone 15mg/5ml oral liquid
0603020T0AAAYAY
|
Prednisolone (Systemic) | Prednisolone | Endocrine System | 2 |
|
Prednisolone sodium phosphate 0.05% eye dps preserv free
1104010S0AABPBP
|
Prednisolone sodium phosphate (Ear/Eye) | Prednisolone sodium phosphate | Eye | 2 |
|
Prednisolone sodium phosphate 0.3% eye drops
1104010S0AABMBM
|
Prednisolone sodium phosphate (Ear/Eye) | Prednisolone sodium phosphate | Eye | 2 |
|
Prednisone 5mg modified-release tablets
0603020X0AAAGAG
|
Prednisone | Prednisone | Endocrine System | 2 |
|
Predsol 5mg suppositories
0105020E0BBAAAA
|
Predsol (Rectal) | Prednisolone sodium phosphate | Gastro-Intestinal System | 2 |
|
PremierPore VP dressing 10cm x 25cm
20030100423
|
PremierPore VP dressing 10cm x 25cm | Wound Management & Other Dressings | Dressings | 2 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.